The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this technique offers a less invasive way to administer https://francesghsj914058.thekatyblog.com/39178952/glp-1-patches-a-novel-approach-to-blood-sugar-treatment